Enabling Precision Medicine with CRISPR-Cas Genome Editing Technology: A Translational Perspective

Area of Science:

• Biotechnology
• Genetics
• Molecular Biology

Background:

• CRISPR-Cas (clustered regularly interspaced short palindromic repeats (CRISPR) associated nucleases) is a powerful genome editing technology.
• This technology enables precise DNA modifications, revolutionizing gene therapy.
• Advancements in sequencing and gene editing pave the way for precision medicine.

Purpose of the Study:

• To explore the challenges and opportunities of CRISPR-Cas for therapeutic gene editing.
• To discuss delivery vehicles for CRISPR-Cas systems.
• To summarize the clinical progress and obstacles for CRISPR-Cas translation.

Main Methods:

• Review of CRISPR-Cas technology and its applications in gene therapy.
• Analysis of delivery systems for CRISPR-Cas components.
• Examination of clinical trial data and regulatory hurdles.

Main Results:

• CRISPR-Cas enables site-specific DNA modifications for treating genetic disorders.
• Potential for correcting pathogenic mutations and introducing therapeutic genomic alterations.
• Clinical translation is nascent, dependent on efficiency, specificity, and delivery.

Conclusions:

• CRISPR-Cas holds immense therapeutic potential but faces significant challenges in clinical translation.
• Delivery vehicles and system optimization are crucial for successful application.
• Continued research and clinical trials are necessary to overcome obstacles and advance CRISPR-Cas gene therapy.